Company intelligence / Profile preview

Avenda Health

Culver City, California, United States

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Avenda Health's Unfold AI and Focal Therapy System have demonstrated safety and the ability to map prostate cancer more comprehensively than standard imaging (up to 97% accuracy compared to 39% for MRI). The Focal Therapy System has completed a Phase I study showing no decline in urinary or sexual function and is working toward additional pivotal clinical trials and PMA approval[1][4][5]. Multiple studies support iQuest’s utility for tumor margin prediction, improving tumor encapsulation in treatment planning from 56% to 80%[5].

Therapeutic areas: Oncology
Modalities: DeviceAI-enabled softwareLaser ablation system
Industry: Therapeutic Medical Devices

Partnerships

BioscienceLA

Beyond the preview

Go deeper on Avenda Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avenda Health.

Explore the full profile